Table 2.
Summary of immune cells in the tumor microenvironment of pancreatic adenocarcinoma.
Immune Cell Type | Infiltration and distribution | Related Cytokines | Function | Prognostic factors associated with PDAC | Other known immune functions | ||
---|---|---|---|---|---|---|---|
Pancreatitis | Pancreatic ductal intraepithelial neoplasia | PDAC | |||||
Neutrophil | High | Present | Very low | IL-8, C5a, MMP | Promoting inflammation, promoting cancer | No difference in various types of PDAC | Resist pathogens such as bacteria and viruses. |
TAM | |||||||
M1 | High | Present | Present | IFN-γ, IL-12, IL-23, TNF-α |
Promoting inflammation, promoting cancer | Participate in th1 type immune response, killing pathogens and tumor cells | |
M2 | Low | Low | High | IL-4, IL-10, IL-13, TGF-β | Immunosuppression | Poor survival rate | Mediates Th2-type immune response and plays a major role |
MDSC | Present | Low | High | GM-CSF, VEGF, TGF-β | Immunosuppression, decreased CD8 + T cell infiltration | Poor survival rate | Suppress immune cell response |
T cell | |||||||
Treg | Present | Low | High | TGF-β, IL-6 | Immunosuppression, decreased CD8 + T cell infiltration | Poor survival rate | Immunosuppression and tolerance. |
Helper T cell | |||||||
Th1 | Present | Low | Low | IL-2, IFN-γ | Immune activation | Better survival rate | Assist in the removal of microorganisms in cells |
Th2 | Present | Low | High | IL-4, IL-5, IL-6, IL-13 | Immunosuppression | Poor survival rate | Participate in allergic reactions against |
Effector T cell | Present | Low | Low | IFN-γ, TNF-α, IL-2 |
Antitumor immunity | Better survival rate | Recognize infected cells and bind to cell |
Th17 cell | IL-17A,IL-17F,IL22,TNF-α | Promoting inflammation | Activate neutrophils, mediate inflammation, and tumor immunity. | ||||
DCs | L12,IL18,cck | Antitumor immunity | Inducing specific CTL anti-tumor immune response. |
TAM, tumor-associated macrophage; VEGF, vascular endothelial growth factor; MDSC, myeloid-derived suppressor cell.